| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |